Home
Categories
EXPLORE
True Crime
Comedy
Business
History
Society & Culture
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/e0/9b/f4/e09bf45a-b30f-b87c-8f2d-29f5e88a1201/mza_5616139513584150856.jpg/600x600bb.jpg
Morgans Under the Microscope
Morgans Financial Limited
96 episodes
14 hours ago
A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.
Show more...
Investing
Business
RSS
All content for Morgans Under the Microscope is the property of Morgans Financial Limited and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.
Show more...
Investing
Business
https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/b24e052c6c3c13fc1383eb8152d86dc5.jpg
Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer
Morgans Under the Microscope
7 minutes
4 years ago
Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer
Senior Analyst Scott Power from the Morgans Healthcare team speaks with Jon Pilcher, Chief Executive Officer of Neuren Pharmaceuticals (ASX:NEU). Jon explains a number of key catalysts which are expected in 2021.
Morgans Under the Microscope
A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.